CLINICAL LEAD
Dr Stephen Laughton works at Starship Blood and Cancer Centre (Auckland) and has been involved in the clinical care of children with cancer since 2000. His specific area of interest and expertise is the management of children with brain tumours.
Stephen completed his initial medical and paediatric training in Auckland and as the inaugural recipient of the Joshua Holland Leukaemia Fund Fellowship in Paediatric Haematology/Oncology Clinical Research, spent three years at the Centre for Children’s Cancer and Blood Disorders, Sydney Children’s Hospital, and the Children’s Cancer Institute Australia. He then went on to train in paediatric neuro-oncology at one of the world’s leading children’s cancer institutions – St Jude Children’s Research Hospital, Memphis, Tennessee, returning to New Zealand in 2007.
Dr Laughton is the Starship Children’s Hospital Principal Investigator for the Children’s Oncology Group (COG). In addition to being an appointed member of the Starship Clinical Excellence Governance Committee, Stephen is also the Health Professional Representative on the Board of the Child Cancer Foundation.